The global Hemostatic Agents market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Hemostatic agents are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure.
The world"s leading manufacturers of hemostatics are Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LiLifeSciences, B Braun Melsungen and Gelita Medical.
This report is a detailed and comprehensive analysis for global Hemostatic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Hemostatic Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Hemostatic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Hemostatic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2020-2031
Global Hemostatic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hemostatic Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hemostatic Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Hemostatic Agents market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
麻豆原创 segment by Application
Hospitals
Surgical Centers
Nursing 麻豆原创s
Major players covered
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom鈥橴p SAS
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hemostatic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hemostatic Agents, with price, sales quantity, revenue, and global market share of Hemostatic Agents from 2020 to 2025.
Chapter 3, the Hemostatic Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hemostatic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hemostatic Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hemostatic Agents.
Chapter 14 and 15, to describe Hemostatic Agents sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Hemostatic Agents Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Gelation Sponge
1.3.3 Oxidized Regenerated Cellulose Based Hemostats
1.3.4 Others
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Hemostatic Agents Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Surgical Centers
1.4.4 Nursing 麻豆原创s
1.5 Global Hemostatic Agents 麻豆原创 Size & Forecast
1.5.1 Global Hemostatic Agents Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Hemostatic Agents Sales Quantity (2020-2031)
1.5.3 Global Hemostatic Agents Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Ethicon
2.1.1 Ethicon Details
2.1.2 Ethicon Major Business
2.1.3 Ethicon Hemostatic Agents Product and Services
2.1.4 Ethicon Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Ethicon Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Hemostatic Agents Product and Services
2.2.4 Pfizer Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Pfizer Recent Developments/Updates
2.3 Baxter International
2.3.1 Baxter International Details
2.3.2 Baxter International Major Business
2.3.3 Baxter International Hemostatic Agents Product and Services
2.3.4 Baxter International Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Baxter International Recent Developments/Updates
2.4 C. R. Bard
2.4.1 C. R. Bard Details
2.4.2 C. R. Bard Major Business
2.4.3 C. R. Bard Hemostatic Agents Product and Services
2.4.4 C. R. Bard Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 C. R. Bard Recent Developments/Updates
2.5 The Medicines Company
2.5.1 The Medicines Company Details
2.5.2 The Medicines Company Major Business
2.5.3 The Medicines Company Hemostatic Agents Product and Services
2.5.4 The Medicines Company Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 The Medicines Company Recent Developments/Updates
2.6 Anika Therapeutics
2.6.1 Anika Therapeutics Details
2.6.2 Anika Therapeutics Major Business
2.6.3 Anika Therapeutics Hemostatic Agents Product and Services
2.6.4 Anika Therapeutics Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Anika Therapeutics Recent Developments/Updates
2.7 Advanced Medical Solutions
2.7.1 Advanced Medical Solutions Details
2.7.2 Advanced Medical Solutions Major Business
2.7.3 Advanced Medical Solutions Hemostatic Agents Product and Services
2.7.4 Advanced Medical Solutions Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Advanced Medical Solutions Recent Developments/Updates
2.8 Integra LifeSciences
2.8.1 Integra LifeSciences Details
2.8.2 Integra LifeSciences Major Business
2.8.3 Integra LifeSciences Hemostatic Agents Product and Services
2.8.4 Integra LifeSciences Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Integra LifeSciences Recent Developments/Updates
2.9 B Braun Melsungen
2.9.1 B Braun Melsungen Details
2.9.2 B Braun Melsungen Major Business
2.9.3 B Braun Melsungen Hemostatic Agents Product and Services
2.9.4 B Braun Melsungen Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 B Braun Melsungen Recent Developments/Updates
2.10 Gelita Medical
2.10.1 Gelita Medical Details
2.10.2 Gelita Medical Major Business
2.10.3 Gelita Medical Hemostatic Agents Product and Services
2.10.4 Gelita Medical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Gelita Medical Recent Developments/Updates
2.11 Equimedical
2.11.1 Equimedical Details
2.11.2 Equimedical Major Business
2.11.3 Equimedical Hemostatic Agents Product and Services
2.11.4 Equimedical Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 Equimedical Recent Developments/Updates
2.12 Vascular Solutions
2.12.1 Vascular Solutions Details
2.12.2 Vascular Solutions Major Business
2.12.3 Vascular Solutions Hemostatic Agents Product and Services
2.12.4 Vascular Solutions Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 Vascular Solutions Recent Developments/Updates
2.13 Marine Polymer Technologies
2.13.1 Marine Polymer Technologies Details
2.13.2 Marine Polymer Technologies Major Business
2.13.3 Marine Polymer Technologies Hemostatic Agents Product and Services
2.13.4 Marine Polymer Technologies Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Marine Polymer Technologies Recent Developments/Updates
2.14 Z-Medica
2.14.1 Z-Medica Details
2.14.2 Z-Medica Major Business
2.14.3 Z-Medica Hemostatic Agents Product and Services
2.14.4 Z-Medica Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Z-Medica Recent Developments/Updates
2.15 CryoLife
2.15.1 CryoLife Details
2.15.2 CryoLife Major Business
2.15.3 CryoLife Hemostatic Agents Product and Services
2.15.4 CryoLife Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 CryoLife Recent Developments/Updates
2.16 BioCer Entwicklungs
2.16.1 BioCer Entwicklungs Details
2.16.2 BioCer Entwicklungs Major Business
2.16.3 BioCer Entwicklungs Hemostatic Agents Product and Services
2.16.4 BioCer Entwicklungs Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 BioCer Entwicklungs Recent Developments/Updates
2.17 Biom鈥橴p SAS
2.17.1 Biom鈥橴p SAS Details
2.17.2 Biom鈥橴p SAS Major Business
2.17.3 Biom鈥橴p SAS Hemostatic Agents Product and Services
2.17.4 Biom鈥橴p SAS Hemostatic Agents Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Biom鈥橴p SAS Recent Developments/Updates
3 Competitive Environment: Hemostatic Agents by Manufacturer
3.1 Global Hemostatic Agents Sales Quantity by Manufacturer (2020-2025)
3.2 Global Hemostatic Agents Revenue by Manufacturer (2020-2025)
3.3 Global Hemostatic Agents Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Hemostatic Agents by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Hemostatic Agents Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Hemostatic Agents Manufacturer 麻豆原创 Share in 2024
3.5 Hemostatic Agents 麻豆原创: Overall Company Footprint Analysis
3.5.1 Hemostatic Agents 麻豆原创: Region Footprint
3.5.2 Hemostatic Agents 麻豆原创: Company Product Type Footprint
3.5.3 Hemostatic Agents 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Hemostatic Agents 麻豆原创 Size by Region
4.1.1 Global Hemostatic Agents Sales Quantity by Region (2020-2031)
4.1.2 Global Hemostatic Agents Consumption Value by Region (2020-2031)
4.1.3 Global Hemostatic Agents Average Price by Region (2020-2031)
4.2 North America Hemostatic Agents Consumption Value (2020-2031)
4.3 Europe Hemostatic Agents Consumption Value (2020-2031)
4.4 Asia-Pacific Hemostatic Agents Consumption Value (2020-2031)
4.5 South America Hemostatic Agents Consumption Value (2020-2031)
4.6 Middle East & Africa Hemostatic Agents Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Hemostatic Agents Sales Quantity by Type (2020-2031)
5.2 Global Hemostatic Agents Consumption Value by Type (2020-2031)
5.3 Global Hemostatic Agents Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Hemostatic Agents Sales Quantity by Application (2020-2031)
6.2 Global Hemostatic Agents Consumption Value by Application (2020-2031)
6.3 Global Hemostatic Agents Average Price by Application (2020-2031)
7 North America
7.1 North America Hemostatic Agents Sales Quantity by Type (2020-2031)
7.2 North America Hemostatic Agents Sales Quantity by Application (2020-2031)
7.3 North America Hemostatic Agents 麻豆原创 Size by Country
7.3.1 North America Hemostatic Agents Sales Quantity by Country (2020-2031)
7.3.2 North America Hemostatic Agents Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Hemostatic Agents Sales Quantity by Type (2020-2031)
8.2 Europe Hemostatic Agents Sales Quantity by Application (2020-2031)
8.3 Europe Hemostatic Agents 麻豆原创 Size by Country
8.3.1 Europe Hemostatic Agents Sales Quantity by Country (2020-2031)
8.3.2 Europe Hemostatic Agents Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Hemostatic Agents Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Hemostatic Agents Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Hemostatic Agents 麻豆原创 Size by Region
9.3.1 Asia-Pacific Hemostatic Agents Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Hemostatic Agents Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Hemostatic Agents Sales Quantity by Type (2020-2031)
10.2 South America Hemostatic Agents Sales Quantity by Application (2020-2031)
10.3 South America Hemostatic Agents 麻豆原创 Size by Country
10.3.1 South America Hemostatic Agents Sales Quantity by Country (2020-2031)
10.3.2 South America Hemostatic Agents Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Hemostatic Agents Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Hemostatic Agents Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Hemostatic Agents 麻豆原创 Size by Country
11.3.1 Middle East & Africa Hemostatic Agents Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Hemostatic Agents Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Hemostatic Agents 麻豆原创 Drivers
12.2 Hemostatic Agents 麻豆原创 Restraints
12.3 Hemostatic Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Hemostatic Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Hemostatic Agents
13.3 Hemostatic Agents Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Hemostatic Agents Typical Distributors
14.3 Hemostatic Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Z-Medica
CryoLife
BioCer Entwicklungs
Biom鈥橴p SAS
听
听
*If Applicable.
